It's estimated that 30% of people with severe depression and suicidal thoughts are diagnosed with treatment-resistant depression. As Dr. Caleb Battersby, director of Interventional Psychiatry at UConn Health explains, esketamine nasal spray works differently than oral antidepressants and typically brings relief within hours or days of receiving the medication.
It's estimated that 30% of people with severe depression and suicidal thoughts are diagnosed with treatment-resistant depression. As Dr. Caleb Battersby, director of Interventional Psychiatry at UConn Health explains, esketamine nasal spray works differently than oral antidepressants and typically brings relief within hours or days of receiving the medication.
/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.
